These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16458790)

  • 1. Recent changes in the spatial pattern of prostate cancer in the U.S.
    Rogerson PA; Sinha G; Han D
    Am J Prev Med; 2006 Feb; 30(2 Suppl):S50-9. PubMed ID: 16458790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended follow-up and spatial analysis of the American Cancer Society study linking particulate air pollution and mortality.
    Krewski D; Jerrett M; Burnett RT; Ma R; Hughes E; Shi Y; Turner MC; Pope CA; Thurston G; Calle EE; Thun MJ; Beckerman B; DeLuca P; Finkelstein N; Ito K; Moore DK; Newbold KB; Ramsay T; Ross Z; Shin H; Tempalski B
    Res Rep Health Eff Inst; 2009 May; (140):5-114; discussion 115-36. PubMed ID: 19627030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Geographically based investigation of prostate cancer mortality in four U.S. Northern Plain states.
    Rusiecki JA; Kulldorff M; Nuckols JR; Song C; Ward MH
    Am J Prev Med; 2006 Feb; 30(2 Suppl):S101-8. PubMed ID: 16458784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for prostate cancer in U.S. men ACPM position statement on preventive practice.
    Lim LS; Sherin K;
    Am J Prev Med; 2008 Feb; 34(2):164-70. PubMed ID: 18201648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries.
    Kvåle R; Auvinen A; Adami HO; Klint A; Hernes E; Møller B; Pukkala E; Storm HH; Tryggvadottir L; Tretli S; Wahlqvist R; Weiderpass E; Bray F
    J Natl Cancer Inst; 2007 Dec; 99(24):1881-7. PubMed ID: 18073376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of PSA screening on the incidence of advanced stage prostate cancer in the United States: a surveillance modeling approach.
    Etzioni R; Gulati R; Falcon S; Penson DF
    Med Decis Making; 2008; 28(3):323-31. PubMed ID: 18319508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate cancer mortality rates compared to urologist population densities and prostate-specific antigen screening levels on a state-by-state basis in the United States of America.
    Colli JL; Amling CL
    Prostate Cancer Prostatic Dis; 2008; 11(3):247-51. PubMed ID: 18268527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spatial analysis of prostate cancer incidence and race in Virginia, 1990-1999.
    Oliver MN; Smith E; Siadaty M; Hauck FR; Pickle LW
    Am J Prev Med; 2006 Feb; 30(2 Suppl):S67-76. PubMed ID: 16458792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downward trend in prostate cancer mortality in Quebec and Canada.
    Meyer F; Moore L; Bairati I; Fradet Y
    J Urol; 1999 Apr; 161(4):1189-91. PubMed ID: 10081867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for prostate cancer.
    Brawley OW; Ankerst DP; Thompson IM
    CA Cancer J Clin; 2009; 59(4):264-73. PubMed ID: 19564245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline prostate-specific antigen level and risk of prostate cancer and prostate-specific mortality: diagnosis is dependent on the intensity of investigation.
    Connolly D; Black A; Gavin A; Keane PF; Murray LJ
    Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):271-8. PubMed ID: 18250343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating lead time and overdiagnosis associated with PSA screening from prostate cancer incidence trends.
    Telesca D; Etzioni R; Gulati R
    Biometrics; 2008 Mar; 64(1):10-9. PubMed ID: 17501937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal gompertzian analysis of mortality from prostate cancer in Japan, 1955-1996.
    Imaizumi Y
    Cancer Detect Prev; 2000; 24(5):473-84. PubMed ID: 11129990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate cancer mortality in relation to screening by prostate-specific antigen testing and digital rectal examination: a population-based study in middle-aged men.
    Agalliu I; Weiss NS; Lin DW; Stanford JL
    Cancer Causes Control; 2007 Nov; 18(9):931-7. PubMed ID: 17641982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in baseline PSA levels in Japanese men from 1988 to 2003.
    Ohi M; Ito K; Yamamoto T; Miyakubo M; Takechi H; Kubota Y; Suzuki K
    Urology; 2008 Jul; 72(1):95-8. PubMed ID: 18455775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men.
    Culp S; Porter M
    BJU Int; 2009 Nov; 104(10):1457-61. PubMed ID: 19522868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Spatial accumulation of mortality and morbidity from cancer of the prostate (ICD-10:C61)].
    Siller G; Páldy A; Nádor G; Vincze I; Zsámbokiné MB; Rajcsányi A; Pintér A
    Magy Onkol; 2002; 46(2):131-7. PubMed ID: 12202892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International trends in prostate-cancer mortality: the decrease is continuing and spreading.
    Baade PD; Coory MD; Aitken JF
    Cancer Causes Control; 2004 Apr; 15(3):237-41. PubMed ID: 15090718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in case mix and treatment patterns in prostate cancer in Saskatchewan during the prostate specific antigen testing era.
    Tonita JM; Skarsgard D; Muhajarine N
    Cancer Causes Control; 2009 Mar; 20(2):201-9. PubMed ID: 18825504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.